NDC 84003-045-01 - DOLCE and GABBANA MEET YOUR FLAWLESS MATTE SKIN DUO - EVERLAST PRIMER EVERLAST FOUNDATION
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 84003-045
- Requested NDC
- 84003-045-01
- Package NDCs from labels
- 84003-045-01
- Manufacturer
- DOLCE & GABBANA BEAUTY SRL | Socoplan | INTERCOS EUROPE SPA
- Effective date
- 2025-09-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| TOCOPHEROL - DOLCE & GABBANA BEAUTY SRL | Socoplan | INTERCOS EUROPE SPA | DOLCE & GABBANA BEAUTY SRL | Socoplan | INTERCOS EUROPE SPA | 2025-09-03 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 84003-045-01 | DOLCE and GABBANA MEET YOUR FLAWLESS MATTE SKIN DUO - EVERLAST PRIMER EVERLAST FOUNDATION | 0.6 mL in 1 BLISTER PACK | EMULSION | 0.6 mL | 50 mg in 1mL | 2 |
| 84003-045-01 | DOLCE and GABBANA MEET YOUR FLAWLESS MATTE SKIN DUO - EVERLAST PRIMER EVERLAST FOUNDATION | 1 in 1 CARTON | EMULSION | 50 mg in 1mL | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 84003-045 | DOLCE AND GABBANA MEET YOUR FLAWLESS MATTE SKIN DUO - EVERLAST PRIMER EVERLAST FOUNDATION (OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE) KIT [DOLCE & GABBANA BEAUTY SRL] | 1 | Unmatched | 20240501_eb63e9c6-bdb0-4bdf-8822-e4561a56adc9.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.